Nanobiotechnology-Based Strategies for Targeting Neuroinflammation and Neural Tissue Engineering
Immuno · 13.03.2026 · 6 (1) · 18
DOI: 10.3390/immuno6010018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immuno, online erschienen am 13.03.2026. Verfasst von Tejas Yuvaraj Suryawanshi und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 303 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology, Ministry of Science and Technology, Technology Mission Division.
Abstract (Originalsprache)
Neuroinflammation is a central hallmark of numerous neurological disorders, including Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, and spinal cord damage. Its persistent and dysregulated nature not only accelerates neuronal loss but also impedes endogenous repair, posing a major challenge for effective therapeutic intervention. Recent advances in nanobiotechnology have opened transformative opportunities to modulate neuroinflammation with unprecedented precision while simultaneously supporting neural regeneration. This review highlights emerging nanomaterial-based strategies including lipid-based, polymeric, inorganic nanoparticles designed to traverse the blood–brain barrier (BBB), deliver anti-inflammatory agents, modulate immune cell behavior, and attenuate glial activation. Extending beyond nanoparticle-based delivery systems, recent advances also emphasize the integration of nanomaterials into biomimetic architectures to provide structural and functional cues for neural repair. We further summarize how these functional nanostructured scaffolds, such as extracellular matrix (ECM) mimetic, nanofibrous and conductive hydrogels, are being leveraged in neural tissue engineering to direct stem cell fate, promote axonal outgrowth, and rebuild damaged neuroarchitectures. Moreover, pharmacokinetics, biodistribution, safety, clinical trials, regulatory considerations and limitations of nanotherapeutics in neurodegenerative diseases are discussed. By outlining the current progress, mechanistic insights, and translational challenges, this review underscores the potential of nanobiotechnology-enabled therapeutics to revolutionize the treatment of neuroinflammatory conditions and advance next-generation neural repair technologies.
Förderung
- Department of Science and Technology, Ministry of Science and Technology, Technology Mission Division
Zitieren
APA
Suryawanshi, T. Y., Redkar, N., Sharma, A., Mishra, J., Saxena, S., & Shukla, S. (2026). Nanobiotechnology-Based Strategies for Targeting Neuroinflammation and Neural Tissue Engineering. Immuno, 6(1), 18. https://doi.org/10.3390/immuno6010018
Vancouver
Suryawanshi TY, Redkar N, Sharma A, Mishra J, Saxena S, Shukla S. Nanobiotechnology-Based Strategies for Targeting Neuroinflammation and Neural Tissue Engineering. Immuno. 2026;6(1):18. doi:10.3390/immuno6010018
BibTeX
@article{Suryawanshi2026,
author = {Suryawanshi, Tejas Yuvaraj and Redkar, Neha and Sharma, Akanksha and Mishra, Jyotsna and Saxena, Sumit and Shukla, Shobha},
title = {Nanobiotechnology-Based Strategies for Targeting Neuroinflammation and Neural Tissue Engineering},
journal = {Immuno},
year = {2026},
volume = {6},
number = {1},
pages = {18},
doi = {10.3390/immuno6010018}
}
EUVIMED